Nomad Power Solutions, Inc. (NMAD) stock
NMADNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.85−0.15 (-5.00%)
Close on Nov 18, 2026Market cap $45.89MP/E –Yield –
Nomad Power Solutions r&d expenses
Research and development expenses are spending on new products and technology.
Nomad Power Solutions's R&D Expenses for the twelve months ending Jun 30, 2026 was $498.44K, down 9.1% year over year. For fiscal 2025 it was $254.92K, down 64.9% from the year before. Over ten years it grew -19.0% a year on average. The highest annual figure on record is $2.09M in fiscal 2015.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $254.92K | -64.9% |
| FY2024 | Dec 31, 2024 | $726.23K | -19.1% |
| FY2023 | Dec 31, 2023 | $898.10K | -33.4% |
| FY2022 | Dec 31, 2022 | $1.35M | -22.3% |
| FY2021 | Dec 31, 2021 | $1.74M | +41.9% |
| FY2020 | Dec 31, 2020 | $1.22M | +49.1% |
| FY2019 | Dec 31, 2019 | $820.91K | +1916.8% |
| FY2018 | Dec 31, 2018 | $40.70K | -91.3% |
| FY2017 | Dec 31, 2017 | $467.26K | -46.3% |
| FY2016 | Dec 31, 2016 | $870.01K | -58.4% |
| FY2015 | Dec 31, 2015 | $2.09M | +87.1% |
| FY2014 | Dec 31, 2014 | $1.12M | +27.1% |
| FY2013 | Dec 31, 2013 | $879.89K | -13.1% |
| FY2012 | Dec 31, 2012 | $1.01M | -24.2% |
| FY2011 | Dec 31, 2011 | $1.33M | +199.6% |
| FY2010 | Dec 31, 2010 | $445.54K | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $62.25K | +2.6% |
| Q1 FY2026 | Mar 31, 2026 | $333.38K | +264.5% |
| Q4 FY2025 | Dec 31, 2025 | $52.12K | +49.6% |
| Q3 FY2025 | Sep 30, 2025 | $50.70K | -86.0% |
| Q2 FY2025 | Jun 30, 2025 | $60.65K | -71.2% |
| Q1 FY2025 | Mar 31, 2025 | $91.46K | -23.2% |
| Q4 FY2024 | Dec 31, 2024 | $34.83K | -76.6% |
| Q3 FY2024 | Sep 30, 2024 | $361.63K | +173.0% |
| Q2 FY2024 | Jun 30, 2024 | $210.71K | -50.7% |
| Q1 FY2024 | Mar 31, 2024 | $119.06K | -37.0% |
| Q4 FY2023 | Dec 31, 2023 | $149.07K | -67.1% |
| Q3 FY2023 | Sep 30, 2023 | $132.49K | -51.4% |
| Q2 FY2023 | Jun 30, 2023 | $427.46K | +159.4% |
| Q1 FY2023 | Mar 31, 2023 | $189.09K | -58.8% |
| Q4 FY2022 | Dec 31, 2022 | $453.62K | -43.6% |
| Q3 FY2022 | Sep 30, 2022 | $272.39K | +19.9% |
| Q2 FY2022 | Jun 30, 2022 | $164.81K | -37.2% |
| Q1 FY2022 | Mar 31, 2022 | $458.45K | +3.4% |
| Q4 FY2021 | Dec 31, 2021 | $803.65K | +279.7% |
| Q3 FY2021 | Sep 30, 2021 | $227.18K | -71.6% |
| Q2 FY2021 | Jun 30, 2021 | $262.42K | +122.5% |
| Q1 FY2021 | Mar 31, 2021 | $443.53K | +368.5% |
| Q4 FY2020 | Dec 31, 2020 | $211.64K | +73.7% |
| Q3 FY2020 | Sep 30, 2020 | $799.42K | +40.1% |
| Q2 FY2020 | Jun 30, 2020 | $117.95K | +47.2% |
| Q1 FY2020 | Mar 31, 2020 | $94.67K | +96.0% |
| Q4 FY2019 | Dec 31, 2019 | $121.87K | +3428.3% |
| Q3 FY2019 | Sep 30, 2019 | $570.60K | +1288.1% |
| Q2 FY2019 | Jun 30, 2019 | $80.12K | +211.9% |
| Q1 FY2019 | Mar 31, 2019 | $48.31K | -53.4% |
| Q3 FY2018 | Sep 30, 2018 | $3.45K | -98.3% |
| Q2 FY2018 | Jun 30, 2018 | $41.11K | +182.3% |
| Q1 FY2018 | Mar 31, 2018 | $25.69K | -82.1% |
| Q4 FY2017 | Dec 31, 2017 | $103.78K | -31.1% |
| Q3 FY2017 | Sep 30, 2017 | $205.67K | -38.8% |
| Q2 FY2017 | Jun 30, 2017 | $14.56K | – |
| Q1 FY2017 | Mar 31, 2017 | $143.24K | – |
| Q4 FY2016 | Dec 31, 2016 | $150.70K | – |
| Q3 FY2016 | Sep 30, 2016 | $335.95K | – |
See a number that looks wrong?